Correlation Between Addex Therapeutics and Cyclerion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Addex Therapeutics and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Addex Therapeutics and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Addex Therapeutics and Cyclerion Therapeutics, you can compare the effects of market volatilities on Addex Therapeutics and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Addex Therapeutics with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Addex Therapeutics and Cyclerion Therapeutics.

Diversification Opportunities for Addex Therapeutics and Cyclerion Therapeutics

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Addex and Cyclerion is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Addex Therapeutics and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and Addex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Addex Therapeutics are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of Addex Therapeutics i.e., Addex Therapeutics and Cyclerion Therapeutics go up and down completely randomly.

Pair Corralation between Addex Therapeutics and Cyclerion Therapeutics

Given the investment horizon of 90 days Addex Therapeutics is expected to under-perform the Cyclerion Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Addex Therapeutics is 8.04 times less risky than Cyclerion Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Cyclerion Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  259.00  in Cyclerion Therapeutics on September 28, 2024 and sell it today you would earn a total of  73.00  from holding Cyclerion Therapeutics or generate 28.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Addex Therapeutics  vs.  Cyclerion Therapeutics

 Performance 
       Timeline  
Addex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Addex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Cyclerion Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclerion Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Cyclerion Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Addex Therapeutics and Cyclerion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Addex Therapeutics and Cyclerion Therapeutics

The main advantage of trading using opposite Addex Therapeutics and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Addex Therapeutics position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.
The idea behind Addex Therapeutics and Cyclerion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets